PHARMACOKINETICS OF METHOTREXATE ADMINISTERED BY INTRAMUSCULAR AND SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:85
作者
BROOKS, PJ [1 ]
SPRUILL, WJ [1 ]
PARISH, RC [1 ]
BIRCHMORE, DA [1 ]
机构
[1] UNIV GEORGIA,COLL PHARM,DEPT PHARM PRACTICE,ATHENS,GA 30602
来源
ARTHRITIS AND RHEUMATISM | 1990年 / 33卷 / 01期
关键词
D O I
10.1002/art.1780330112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The serum concentrations and the pharmacokinetics of low‐dose methotrexate (MTX) were compared after both intramuscular (IM) and subcutaneous (SQ) injections in 5 patients with rheumatoid arthritis. Values for the observed peak concentration, the time to the observed peak concentration, and the area under the time versus concentration curve for IM injections were not significantly different from these values for SQ injections. These results suggest that IM and SQ are interchangeable routes of administration. SQ administration may be a more convenient and less painful way of administering low‐dose MTX. Copyright © 1990 American College of Rheumatology
引用
收藏
页码:91 / 94
页数:4
相关论文
共 13 条
[1]   PHARMACOKINETICS OF SUBCUTANEOUS METHOTREXATE [J].
BALIS, FM ;
MIRRO, J ;
REAMAN, GH ;
EVANS, WE ;
MCCULLY, C ;
DOHERTY, KM ;
MURPHY, RF ;
JEFFRIES, S ;
POPLACK, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1882-1886
[2]  
CAMPBELL MA, 1985, CANCER TREAT REP, V69, P833
[3]  
EVANS WE, 1986, METHOTREXATE APPLIED
[4]  
FREEMANNARROD M, 1975, CANCER, V36, P1619, DOI 10.1002/1097-0142(197511)36:5<1619::AID-CNCR2820360514>3.0.CO
[5]  
2-G
[6]  
HEALEY LA, 1986, B RHEUM DIS, V36, P1
[7]   IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY PROPERTIES OF CYCLOPHOSPHAMIDE, AZATHIOPRINE AND METHOTREXATE [J].
HURD, ER .
ARTHRITIS AND RHEUMATISM, 1973, 16 (01) :84-88
[8]  
KAMEL RS, 1988, ACTA DERM-VENEREOL, V68, P267
[9]  
LENTENDRE PW, 1985, DRUG INTELL CLIN PHA, V19, P349
[10]   WEEKLY INTRAVENOUS METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS [J].
MICHAELS, RM ;
NASHEL, DJ ;
LEONARD, A ;
SLIWINSKI, AJ ;
DERBES, SJ .
ARTHRITIS AND RHEUMATISM, 1982, 25 (03) :339-341